About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in New York | 35 Studies

Clinical Trials COPDNew York

COPD Clinical Trials in New York

Find 35 clinical trials for copd near New York, New York. Connect with research centers in your area.

All COPD trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-35 of 35 trials

RecruitingA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseThe purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD.NCT07363694·Birmingham, Alabama and 119 others

COPD Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedCapnography-Assisted Learned Monitored (CALM) Breathing Therapy for COPDThis pilot study is part of a phased approach to refine, optimize, and test the feasibility of CALM Breathing.NCT04786184·New York, New York and 1 other

CompletedCapnometry-Assisted Breathing Training for COPDCapnometry-Assisted Breathing Training for COPD (CATCH) is a behavioral intervention that aims to promote optimal, self-regulated, mindful breathing.NCT03457103·New York, New York

CompletedPivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 InflammationPrimary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate-or severe Chronic Obstructive Pulmonary Disease (COPD) as measured…NCT03930732·Andalusia, Alabama and 274 others

RecruitingLung Microbiome and Inflammation in Early COPDThis is a cross sectional case controlled study to assess lung microbiome and inflammation in smokers with and without Chronic Obstructive Pulmonary Disease (COPD).NCT02777879·New York, New York

Active not recruitingA Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseThis study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COPD) who are former or current…NCT05595642·Birmingham, Alabama and 381 others

CompletedLosartan Effects on Emphysema ProgressionA randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to…NCT02696564·Birmingham, Alabama and 27 others

CompletedAdverse Health Effects of Mainstream and Secondhand Hookah Smoke in NYC Hookah BarsThe primary purpose of this study is to examine the health effects of mainstream and secondhand hookah (i.e. water pipe) smoke on pulmonary and cardiovascular functions as well as…NCT02638194·New York, New York

CompletedThe Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory DiseasesThe objective of this study is to look at the effects of distractive auditory stimuli (DAS) on reducing dyspnea intensity and related anxiety and increasing exercise tolerance.NCT02955108·New York, New York

CompletedA Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPDThis is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide…NCT06208306·Chandler, Arizona and 222 others

TerminatedA Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) SubjectsThis is a randomized, open-label, parallel group, multicenter, outpatient study in COPD subjects who are discharged from the hospital due to a COPD exacerbation.NCT02275481·Birmingham, Alabama and 27 others

Enrolling by invitationTitrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional HypoxemiaFibrotic forms of interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) are chronic lung disease which often affect how well oxygen can get from the…NCT07512687·Buffalo, New York

CompletedStudy to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)Primary Objective: Primary population (former smokers cohort): * Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe…NCT04751487·Phoenix, Arizona and 296 others

Active not recruitingA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have…NCT05878769·Birmingham, Alabama and 480 others

TerminatedBeta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseThis is a multicenter, prospective, randomized, double-blind, placebo-controlled trial that will enroll 1028 patients with at least moderately severe COPD over a three year period…NCT02587351·Birmingham, Alabama and 26 others

PreviousPage 2 of 2

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia